Javier Rubio
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Javier Rubio has a total of 44 co-authors. Here are the top co-authors by number of shared publications:
- Anna M. Aragay
Department of Biomedicine, University of Bergen, Bergen, Norway
2 shared publications - Marc Liesa
Institut de Biologia Molecular de Barcelona, IBMB, CSIC, Barcelona, Catalonia, Spain
2 shared publications - Aditya Sivakumar
Department of Biological Chemistry, David Geffen School of Medicine, UCLA, Los Angeles, USA
1 shared publication Adolfo López de Munain
Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas (CIBER-CIBERNED), ISCIII, Madrid 28031, Spain
1 shared publicationAdrian Baumann
Institute for Molecular Biology of Barcelona (IBMB, CSIC), Baldiri Reixac 15
1 shared publicationAjit S. Divakaruni
Department of Molecular and Medical Pharmacology, David Geffen School of Medicine, UCLA, Los Angeles, USA
1 shared publication
Latest Publications
- Open Access
- 27 April 2026
- Published by Springer Nature in Nature Chemistry
- p. 1-12
Small-molecule binding-site discovery using silyl ether-enabled chemoproteomics
For chemical probe and drug discovery campaigns, the pairing of mass spectrometry-based chemoproteomics with photoaffinity labelling has emerged as a favoured approach for target discovery and mode of action assignment. However, photocrosslinked peptide-compound adducts raise analytic challenges for quantitative binding site discovery. Here, to address these challenges, we establish the Silyl Ether Enables Chemoproteomic Interaction and Target Engagement (SEE-CITE) method. SEE-CITE incorporates a fully functionalized chemically cleavable photocrosslinking handle that enables precise site-of-labelling identification and head-to-head comparisons of relative binding site engagement by chemically diverse compounds. To ensure high-confidence localization of labelled residues, we extended the MSFragger algorithm of the FragPipe computational platform to report localization scores customized for photoaffinity labelling and SEE-CITE data. When applied to scout fragments and analogues of select FDA-approved kinase inhibitors, SEE-CITE delineates known drug binding sites and uncovers small-molecule binding sites that affect the protein activity of RTN4 and COX5A.
- 27 April 2026
- Published by Springer Nature in Nature Chemistry
- p. 1-12
Open AccessSmall-molecule binding-site discovery using silyl ether-enabled chemoproteomics
For chemical probe and drug discovery campaigns, the pairing of mass spectrometry-based chemoproteomics with photoaffinity labelling has emerged as a favoured approach for target discovery and mode of action assignment. However, photocrosslinked peptide-compound adducts raise analytic challenges for quantitative binding site discovery. Here, to address these challenges, we establish the Silyl Ether Enables Chemoproteomic Interaction and Target Engagement (SEE-CITE) method. SEE-CITE incorporates a fully functionalized chemically cleavable photocrosslinking handle that enables precise site-of-labelling identification and head-to-head comparisons of relative binding site engagement by chemically diverse compounds. To ensure high-confidence localization of labelled residues, we extended the MSFragger algorithm of the FragPipe computational platform to report localization scores customized for photoaffinity labelling and SEE-CITE data. When applied to scout fragments and analogues of select FDA-approved kinase inhibitors, SEE-CITE delineates known drug binding sites and uncovers small-molecule binding sites that affect the protein activity of RTN4 and COX5A.
- Open Access
- 17 November 2025
- Published by Springer Nature in The EMBO Journal
- Vol. 44 (24) , 7334-7345
Measuring mitochondrial membrane potential
Mitochondrial function determines the balance between health and disease, making understanding their bioenergetics an increasingly important focus across biomedical research. Among the most relevant and accessible measures of mitochondrial function in intact cells is the mitochondrial membrane potential (ΔΨm), typically determined with commercially available fluorescent dyes. However, these probes are prone to misjudgement, as oversimplified interpretation of their fluorescent signal can cause important mistakes during both data acquisition and conclusions. This metabolism methods commentary describes how the interplay between mitochondrial membrane potential, mitochondrial ATP synthesis and oxygen consumption influences ΔΨm as a readout for mitochondrial respiratory function. We then examine how widely used mitochondrial dyes label mitochondria and what their fluorescence really reflects. Finally, we highlight four hallmark principles for the accurate determination of mitochondrial ΔΨm, which we hope will promote the rigorous assessment and interpretation of mitochondrial membrane potential across research fields.
- 17 November 2025
- Published by Springer Nature in The EMBO Journal
- Vol. 44 (24) , 7334-7345
Open AccessMeasuring mitochondrial membrane potential
Mitochondrial function determines the balance between health and disease, making understanding their bioenergetics an increasingly important focus across biomedical research. Among the most relevant and accessible measures of mitochondrial function in intact cells is the mitochondrial membrane potential (ΔΨm), typically determined with commercially available fluorescent dyes. However, these probes are prone to misjudgement, as oversimplified interpretation of their fluorescent signal can cause important mistakes during both data acquisition and conclusions. This metabolism methods commentary describes how the interplay between mitochondrial membrane potential, mitochondrial ATP synthesis and oxygen consumption influences ΔΨm as a readout for mitochondrial respiratory function. We then examine how widely used mitochondrial dyes label mitochondria and what their fluorescence really reflects. Finally, we highlight four hallmark principles for the accurate determination of mitochondrial ΔΨm, which we hope will promote the rigorous assessment and interpretation of mitochondrial membrane potential across research fields.
- 6 February 2024
- Published by American Association for the Advancement of Science (AAAS) in Science Signaling
- Vol. 17 (822) , eabq1007
A mammalian-specific Alex3/Gα q protein complex regulates mitochondrial trafficking, dendritic complexity, and neuronal survival
Mitochondrial dynamics and trafficking are essential to provide the energy required for neurotransmission and neural activity. We investigated how G protein–coupled receptors (GPCRs) and G proteins control mitochondrial dynamics and trafficking. The activation of Gα q inhibited mitochondrial trafficking in neurons through a mechanism that was independent of the canonical downstream PLCβ pathway. Mitoproteome analysis revealed that Gα q interacted with the Eutherian-specific mitochondrial protein armadillo repeat–containing X-linked protein 3 (Alex3) and the Miro1/Trak2 complex, which acts as an adaptor for motor proteins involved in mitochondrial trafficking along dendrites and axons. By generating a CNS-specific Alex3 knockout mouse line, we demonstrated that Alex3 was required for the effects of Gα q on mitochondrial trafficking and dendritic growth in neurons. Alex3-deficient mice had altered amounts of ER stress response proteins, increased neuronal death, motor neuron loss, and severe motor deficits. These data revealed a mammalian-specific Alex3/Gα q mitochondrial complex, which enables control of mitochondrial trafficking and neuronal death by GPCRs.
- 6 February 2024
- Published by American Association for the Advancement of Science (AAAS) in Science Signaling
- Vol. 17 (822) , eabq1007
A mammalian-specific Alex3/Gα q protein complex regulates mitochondrial trafficking, dendritic complexity, and neuronal survival
Mitochondrial dynamics and trafficking are essential to provide the energy required for neurotransmission and neural activity. We investigated how G protein–coupled receptors (GPCRs) and G proteins control mitochondrial dynamics and trafficking. The activation of Gα q inhibited mitochondrial trafficking in neurons through a mechanism that was independent of the canonical downstream PLCβ pathway. Mitoproteome analysis revealed that Gα q interacted with the Eutherian-specific mitochondrial protein armadillo repeat–containing X-linked protein 3 (Alex3) and the Miro1/Trak2 complex, which acts as an adaptor for motor proteins involved in mitochondrial trafficking along dendrites and axons. By generating a CNS-specific Alex3 knockout mouse line, we demonstrated that Alex3 was required for the effects of Gα q on mitochondrial trafficking and dendritic growth in neurons. Alex3-deficient mice had altered amounts of ER stress response proteins, increased neuronal death, motor neuron loss, and severe motor deficits. These data revealed a mammalian-specific Alex3/Gα q mitochondrial complex, which enables control of mitochondrial trafficking and neuronal death by GPCRs.
- Open Access
- 25 April 2023
- Published by eLife Sciences Publications, Ltd in eLife
- Vol. 12
Kazrin promotes dynein/dynactin-dependent traffic from early to recycling endosomes
Kazrin is a protein widely expressed in vertebrates whose depletion causes a myriad of developmental defects, in part derived from altered cell adhesion and migration, as well as failure to undergo epidermal to mesenchymal transition. However, the primary molecular role of kazrin, which might contribute to all these functions, has not been elucidated yet. We previously identified one of its isoforms, kazrin C, as a protein that potently inhibits clathrin-mediated endocytosis when overexpressed. We now generated kazrin knock-out mouse embryonic fibroblasts to investigate its endocytic function. We found that kazrin depletion delays juxtanuclear enrichment of internalized material, indicating a role in endocytic traffic from early to recycling endosomes. Consistently, we found that the C-terminal domain of kazrin C, predicted to be an intrinsically disordered region, directly interacts with several early endosome (EE) components, and that kazrin depletion impairs retrograde motility of these organelles. Further, we noticed that the N-terminus of kazrin C shares homology with dynein/dynactin adaptors and that it directly interacts with the dynactin complex and the dynein light intermediate chain 1. Altogether, the data indicate that one of the primary kazrin functions is to facilitate endocytic recycling by promoting dynein/dynactin-dependent transport of EEs or EE-derived transport intermediates to the recycling endosomes.
- 25 April 2023
- Published by eLife Sciences Publications, Ltd in eLife
- Vol. 12
Open AccessKazrin promotes dynein/dynactin-dependent traffic from early to recycling endosomes
Kazrin is a protein widely expressed in vertebrates whose depletion causes a myriad of developmental defects, in part derived from altered cell adhesion and migration, as well as failure to undergo epidermal to mesenchymal transition. However, the primary molecular role of kazrin, which might contribute to all these functions, has not been elucidated yet. We previously identified one of its isoforms, kazrin C, as a protein that potently inhibits clathrin-mediated endocytosis when overexpressed. We now generated kazrin knock-out mouse embryonic fibroblasts to investigate its endocytic function. We found that kazrin depletion delays juxtanuclear enrichment of internalized material, indicating a role in endocytic traffic from early to recycling endosomes. Consistently, we found that the C-terminal domain of kazrin C, predicted to be an intrinsically disordered region, directly interacts with several early endosome (EE) components, and that kazrin depletion impairs retrograde motility of these organelles. Further, we noticed that the N-terminus of kazrin C shares homology with dynein/dynactin adaptors and that it directly interacts with the dynactin complex and the dynein light intermediate chain 1. Altogether, the data indicate that one of the primary kazrin functions is to facilitate endocytic recycling by promoting dynein/dynactin-dependent transport of EEs or EE-derived transport intermediates to the recycling endosomes.